Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

US Patent 10821107 · Granted Nov 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GRP94 selective inhibitors and uses thereof2024
HSP90 activator AHA1 drives production of pathological tau aggregates2024
Hsp90 activator Aha1 drives production of pathological tau aggregates2022
Grp94 selective inhibitors and uses thereof2021
Transgenic mouse model for conditional FKBP51 expression and related methods2020
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseas2019
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseas2019
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods 2018
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods 2018
Pharmaceutical compounds and use of same in cancer and tauopathies2017
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseas2017
Conversion of non-neuronal cells into neurons2016